Could a common steroid save lives in severe sepsis lung failure?
NCT ID NCT07576660
First seen May 11, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study tests whether the steroid dexamethasone, when added to standard care, can lower the chance of death within 90 days for people with severe lung injury (ARDS) caused by sepsis. About 1,474 adults on breathing machines will be randomly assigned to receive either dexamethasone or a placebo. The goal is to see if this anti-inflammatory drug helps more people survive and recover.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongda Hospital, School of Medicine, Southeast University
Nanjing, Jiangsu, 210009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.